Free cash flow
Pfizer Free cash flow increased by 12.5% to $4.50B in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 22.4%, from $5.80B to $4.50B. Over 4 years (FY 2021 to FY 2025), Free cash flow shows a downward trend with a -25.8% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase suggests strong operational efficiency and the ability to self-fund future innovation or return capital to shareholders, while a decrease may indicate heavy capital expenditure cycles or declining operational profitability.
Detailed definition
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and m...
Peer comparison
High-growth semiconductor and AI infrastructure peers typically prioritize reinvestment, so free cash flow margins are often compared against R&D intensity and capital expenditure requirements of industry rivals.
cf_free_cash_flowHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $10.76B | $10.21B | $4.92B | $5.90B | $7.42B | $5.13B | $7.58B | $73.00M | -$2.12B | $2.65B | $4.20B | $386.00M | -$2.42B | $6.06B | $5.80B | $1.77B | -$1.20B | $4.00B | $4.50B |
| QoQ Change | — | -5.1% | -51.8% | +19.9% | +25.8% | -30.8% | +47.7% | -99.0% | <-999% | +224.7% | +58.6% | -90.8% | -726.4% | +350.7% | -4.3% | -69.5% | -167.8% | +433.4% | +12.5% |
| YoY Change | — | — | — | — | -31.0% | -49.7% | +54.1% | -98.8% | -128.6% | -48.5% | -44.7% | +428.8% | -13.9% | +129.1% | +38.3% | +358.8% | +50.4% | -34.0% | -22.4% |
Free cash flow at Other Companies
Frequently Asked Questions
- What is Pfizer's free cash flow?
- Pfizer (PFE) reported free cash flow of $4.50B in Q4 2025.
- How has Pfizer's free cash flow changed year-over-year?
- Pfizer's free cash flow decreased by 22.4% year-over-year, from $5.80B to $4.50B.
- What is the long-term trend for Pfizer's free cash flow?
- Over 4 years (2021 to 2025), Pfizer's free cash flow has grown at a -25.8% compound annual growth rate (CAGR), from $29.87B to $9.08B.
- What does free cash flow mean?
- The cash a company has left over after paying for its operating expenses and capital investments.